149 related articles for article (PubMed ID: 25553509)
21. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
[TBL] [Abstract][Full Text] [Related]
22. Novel benzimidazol-2-ylidene carbene precursors and their silver(I) complexes: Potential antimicrobial agents.
Kaloğlu M; Kaloğlu N; Özdemir İ; Günal S; Özdemir İ
Bioorg Med Chem; 2016 Aug; 24(16):3649-56. PubMed ID: 27301680
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of sandwich type acyclic tetra-nuclear silver(I)-N-heterocyclic carbene complexes for wound healing applications.
Riaz A; Iqbal MA; Bhatti HN; Shahid M
Z Naturforsch C J Biosci; 2020 Sep; 75(9-10):369-376. PubMed ID: 32589611
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2-naphthoquinone thiosemicarbazones.
Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1192-8. PubMed ID: 22978426
[TBL] [Abstract][Full Text] [Related]
26. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, characterization, crystal structure, α-glycosidase, and acetylcholinesterase inhibitory properties of 1,3-disubstituted benzimidazolium salts.
Bal S; Demirci Ö; Şen B; Taslimi P; Aktaş A; Gök Y; Aygün M; Gülçin İ
Arch Pharm (Weinheim); 2021 May; 354(5):e2000422. PubMed ID: 33427318
[TBL] [Abstract][Full Text] [Related]
28. meta-Cyanobenzyl substituted benzimidazolium salts: Synthesis, characterization, crystal structure and carbonic anhydrase, α-glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties.
Türker F; Barut Celepci D; Aktaş A; Taslimi P; Gök Y; Aygün M; Gülçin İ
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800029. PubMed ID: 29963738
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and antitumor cytotoxicity of novel bis-benzimidazoles.
Singh AK; Lown JW
Anticancer Drug Des; 2000 Aug; 15(4):265-75. PubMed ID: 11200502
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.
Abu Bakar A; Akhtar MN; Mohd Ali N; Yeap SK; Quah CK; Loh WS; Alitheen NB; Zareen S; Ul-Haq Z; Shah SAA
Molecules; 2018 Mar; 23(3):. PubMed ID: 29518053
[TBL] [Abstract][Full Text] [Related]
33. Anticancer, antimicrobial and antioxidant potential of sterically tuned bis-N-heterocyclic salts.
Huda NU; Islam S; Zia M; William K; Abbas FI; Umar MI; Iqbal MA; Mannan A
Z Naturforsch C J Biosci; 2018 Dec; 74(1-2):17-23. PubMed ID: 30500781
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and potential cytotoxic activity of some new benzoxazoles, imidazoles, benzimidazoles and tetrazoles.
Arulmurugan S; Kavitha HP
Acta Pharm; 2013 Jun; 63(2):253-64. PubMed ID: 23846147
[TBL] [Abstract][Full Text] [Related]
35. Sterically modulated silver(I) complexes of coumarin substituted benzimidazol-2-ylidenes: Synthesis, crystal structures and evaluation of their antimicrobial and antilung cancer potentials.
Achar G; Shahini CR; Patil SA; Małecki JG; Pan SH; Lan A; Chen XR; Budagumpi S
J Inorg Biochem; 2018 Jun; 183():43-57. PubMed ID: 29529471
[TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis and Cytotoxicity Evaluation of New 3, 5-Disubstituted-2-Thioxoimidazolidinones.
Abdellatif KRA; Elbadawi MM; Elsaady MT; Abd El-Hafeez AA; Fujimura T; Kawamoto S; Khodair AI
Anticancer Agents Med Chem; 2018; 18(4):573-582. PubMed ID: 29189182
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents.
Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Kumar CG; Pombala S; Sridhar B
Eur J Med Chem; 2014 May; 79():260-5. PubMed ID: 24742385
[TBL] [Abstract][Full Text] [Related]
38. A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines.
Anjomshoa M; Hadadzadeh H; Torkzadeh-Mahani M; Fatemi SJ; Adeli-Sardou M; Rudbari HA; Nardo VM
Eur J Med Chem; 2015; 96():66-82. PubMed ID: 25874332
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines.
Stýskala J; Stýskalová L; Slouka J; Hajdúch M
Eur J Med Chem; 2008 Mar; 43(3):449-55. PubMed ID: 18272255
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents.
El-Gohary NS; Shaaban MI
Eur J Med Chem; 2017 May; 131():255-262. PubMed ID: 28334654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
